BofA raised the firm’s price target on Alignment Healthcare to $8.50 from $7.25 and keeps a Neutral rating on the shares. MCOs were pressured in 2023 from sector rotation, heightened regulatory scrutiny, trend concerns, and deal uncertainty, but broadly the firm remains bullish on managed care and sees 2024 being about the group resetting expectations, getting back to consistent beats and raises and working through overhangs.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ALHC:
- Alignment Healthcare, musician Luis Miguel partner for campaign
- Alignment Healthcare price target lowered to $8 from $10 at TD Cowen
- Alignment Healthcare Reports Third Quarter 2023 Results; Exceeds Guidance Across All Key Financial Metrics
- Alignment Healthcare sees FY23 revenue $1.78B-$1.8B, consensus $1.78B
- Alignment Healthcare sees Q4 revenue $422M-$442M, consensus $434.86M